Get the Stockscreener App
104.32
0.26%
0.27
After Hours:
104.32
Zimmer Biomet Holdings Inc stock is traded at $104.32, with a volume of 2.67M.
It is up +0.26% in the last 24 hours and down -4.71% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$104.05
Open:
$104.81
24h Volume:
2.67M
Relative Volume:
1.68
Market Cap:
$20.77B
Revenue:
$7.60B
Net Income/Loss:
$1.08B
P/E Ratio:
19.83
EPS:
5.26
Net Cash Flow:
$1.26B
1W Performance:
-0.49%
1M Performance:
-4.71%
6M Performance:
-9.65%
1Y Performance:
-16.11%
1-Day Range:
$102.42
$105.56
1-Week Range:
$102.42
$107.64
52-Week Range:
$97.69
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
104.32 | 20.77B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
138.01 | 239.35B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.79 | 153.17B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
386.19 | 147.36B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.02 | 118.00B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.62 | 42.24B | 5.72B | 4.17B | 490.10M | 6.97 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Zimmer Biomet announces definitive agreement to Acquire Paragon 28 - Today's Medical Developments
Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24 - Yahoo Finance
Is the Market Bullish or Bearish on Zimmer Biomet Holdings? - Benzinga
Prosthetic Disc Nucleus Market Outlook to Exceed US$ 265.8 Million by 2034, Driven by Minimally Invasive Surgery Innovations | Latest Report by Transparency Market Research Inc. - GlobeNewswire Inc.
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference - Quantisnow
Zimmer Biomet Announces New Schwarzenegger-Led Campaign - Pharmaceutical Executive
Tekcem bone cement: A breakthrough launch by Zimmer Biomet Holdings - Healthcare Radius
Zimmer Biomet’s $1.75 Billion Notes Offering - Global Legal Chronicle
Weil Advises Underwriters on Zimmer Biomet’s $1.75 Billion Notes Offering - Legal Desire News Network
Zimmer Biomet names Jehanzeb Noor as new strategy and innovation chief - Investing.com Canada
Can Zimmer Biomet's New Strategy Chief Transform Its Acquisition Approach? MIT-Educated Executive Takes Helm - StockTitan
Zimmer Biomet Launches You’ll Be Back Campaign With Chief Movement Officer Arnold Schwarzenegger - Times-Union Newspaper
Zimmer Biomet sets quarterly dividend at $0.24 per share By Investing.com - Investing.com Australia
Zimmer Biomet and Arnold Schwarzenegger promote joint health via new campaign - Yahoo Finance
Ivan Tornos to chair Zimmer Biomet board, company launches new campaign with Arnold Schwarzenegger - Mass Device
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025 - The Malaysian Reserve
Zimmer Biomet Launches You’ll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger - MultiVu
Zimmer Biomet Launches You'll Be Back Campaign With Chief Movement Officer Arnold Schwarzenegger - MENAFN.COM
Can Arnold Schwarzenegger Help Millions With Joint Pain? Zimmer Biomet's New Campaign Says Yes - StockTitan
Zimmer Biomet sets quarterly dividend at $0.24 per share - Investing.com
Zimmer Biomet names new chairman, lead independent director By Investing.com - Investing.com Canada
Zimmer Biomet names new chairman, lead independent director - Investing.com India
Zimmer Biomet Holdings, Inc. Announces Board Changes -February 25, 2025 at 04:05 pm EST - Marketscreener.com
Zimmer Biomet launches Tekcem antibiotic bone cements in India - BSI bureau
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Zimmer Biomet Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Zimmer Biomet issues new notes, details merger agreement terms By Investing.com - Investing.com Nigeria
Zimmer Biomet issues new notes, details merger agreement terms - Investing.com
This Zimmer Biomet Holdings Insider Reduced Their Stake By 71% - Simply Wall St
Zimmer Biomet's SWOT analysis: medical device maker's stock faces ERP hurdles - MSN
Hourglass Capital LLC Has $7.12 Million Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink? - MSN
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, market expansion - Investing.com Nigeria
Zimmer Biomet enters a distribution agreement with Promamec in Morocco - ZAWYA
Rhumbline Advisers Reduces Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ZBH Stock Hurt by Margin Concerns and Difficult Solvency - Yahoo Finance
AlphaCentric Advisors LLC Makes New $623,000 Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
74,083 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Acquired by KLCM Advisors Inc. - MarketBeat
Legacy Capital Wealth Partners LLC Makes New Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Chevy Chase Trust Holdings LLC Trims Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
New York State Teachers Retirement System Has $17.82 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
MFG Wealth Management Inc. Acquires Shares of 14,259 Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet price target lowered to $111 from $122 at Bernstein - MSN
Van ECK Associates Corp Buys 218,688 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
4,201 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Purchased by Roman Butler Fullerton & Co. - MarketBeat
103,508 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Bought by Strategic Financial Concepts LLC - MarketBeat
Zimmer Biomet (NYSE:ZBH) Hits New 12-Month LowTime to Sell? - MarketBeat
Allspring Global Investments Holdings LLC Trims Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
State of Alaska Department of Revenue Sells 6,280 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Purchases 22,396 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):